The Prevalence of Carbapenemase-Producing Microorganisms and Use of Novel Cephalosporins for the Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria in a Pediatric Cardiac Intensive Care Unit

The Prevalence of Carbapenemase-Producing Microorganisms and Use of Novel Cephalosporins for the Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria in a Pediatric Cardiac Intensive Care Unit

Background: The spread of carbapenem-resistant organisms (CROs) is an increasingly serious threat globally, especially in vulnerable populations, such as intensive care unit (ICU) patients. Currently, the antibiotic options for CROs are very limited, particularly in pediatric settings. We describe a...

Full description

Bibliographic Details
Main Authors: Costanza Tripiciano, Lorenza Romani, Stefania Mercadante, Laura Cursi, Martina Di Giuseppe, Francesca Ippolita Calo Carducci, Tiziana Fragasso, Luca Di Chiara, Cristiana Garisto, Annamaria Sisto, Leonardo Vallesi, Valentino Costabile, Laura Lancella, Paola Bernaschi, Maia De Luca
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Antibiotics
Subjects:
carbapenemase
novel cephalosporins
pediatric ICU
Online Access:https://www.mdpi.com/2079-6382/12/5/796

Internet

https://www.mdpi.com/2079-6382/12/5/796

Similar Items